inTRAvent Medical
Private Company
Funding information not available
Overview
inTRAvent Medical is a neuro-focused medical device company commercializing its FDA-cleared SOLOPASS® system, a portable neuro-navigation platform that combines 2D/3D ultrasound, AI, and trajectory guidance for bedside procedures like EVD placement. The technology, conceptualized at Penn State Hershey Medical Center, addresses a century-old procedural standard with high variability. The company is led by a team of neurosurgeons and medical device executives and is exploring expansion into adjacent applications such as hematoma evacuation for hemorrhagic stroke.
Technology Platform
Portable neuro-navigation platform integrating 2D/3D ultrasound imaging, artificial intelligence, and trajectory guidance for bedside neurosurgical procedures.
Opportunities
Risk Factors
Competitive Landscape
The company competes against the entrenched standard of freehand EVD placement and traditional, bulky operating room-based surgical navigation systems from giants like Medtronic and Stryker. Its primary differentiation is portability and bedside usability, creating a niche currently underserved by major players.